Zeng Ling 4
4 · Dicerna Pharmaceuticals Inc · Filed Sep 17, 2021
Insider Transaction Report
Form 4
Zeng Ling
Chief Legal Officer & Sec'y
Transactions
- Exercise/Conversion
Common Stock
2021-09-15+4,556→ 4,556 total - Exercise/Conversion
Restricted Stock Units
2021-09-15−4,556→ 13,669 total→ Common Stock (4,556 underlying) - Sale
Common Stock
2021-09-17$21.47/sh−1,334$28,641→ 3,222 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs and does not represent a discretionary trade by the Reporting Person.
- [F3]Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of September 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date